Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
about
Proteomics Research in SchizophreniaThe schizophrenia risk gene product miR-137 alters presynaptic plasticity.Focus on psychosis.Novel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity DisorderThe proteome of schizophrenia.Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia.Genetic Relationship between Schizophrenia and Nicotine Dependence.Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients.Reduced protein synthesis in schizophrenia patient-derived olfactory cells.The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the SynapseAnkyrin-3 as a molecular marker of early-life stress and vulnerability to psychiatric disorders.Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions.Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Dysregulations of Synaptic Vesicle Trafficking in SchizophreniaPsychiatric disorders biochemical pathways unraveled by human brain proteomics.Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder.From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa.Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence.Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders.Gene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia.Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort.Key players in neurodegenerative disorders in focus-New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis-24th HUPO BPP Workshop: September 29, 2015, Vancouver, Canada.Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders.Proteomics in the Diagnosis of Inborn Encephalopathies of Unknown Origin: A Myth or Reality.Dlgap1 knockout mice exhibit alterations of the postsynaptic density and selective reductions in sociability.The Alteration of ZiBuPiYin Recipe on Proteomic Profiling of Forebrain Postsynaptic Density of db/db Mice with Diabetes-Associated Cognitive Decline.Clozapine influences cytoskeleton structure and calcium homeostasis in rat cerebral cortex and has a different proteomic profile than risperidone.Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.New considerations for hiPSC-based models of neuropsychiatric disorders.Proteomic study revealed antipsychotics-induced nuclear protein regulations in B35 cells are similar to the regulations in C6 cells and rat cortex.Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights
P2860
Q26766821-A2FA865B-39A0-4253-A3DB-19BAA4132AD8Q27312392-3BD5CAC4-DEE0-4092-BE46-1EEF591BC00CQ35575042-C33F59D7-29EB-4B8A-95C4-2F8EE147C8B5Q36594944-E26F356C-6304-4F02-B8D1-50911C76B268Q36656889-9AE66CCB-9623-4E28-BCF0-78E17C87B9FBQ36848272-8DB9B859-935E-4692-9BA0-1033E24115A3Q36848319-94BD171E-50AC-47C3-8A49-7DA731AD92D3Q36887530-E689D1DB-6EE0-4A49-A5D3-95D2CC17C876Q37058606-4CA69540-B720-47F9-9CDE-B8EE622325E0Q37058610-4F0BD33E-3641-4824-9757-5E3A4B46906EQ37490360-0A7EF451-8BEA-4AEF-8EF3-D8DBDD673C7DQ37648269-E1604C97-BF59-41A6-A9B1-587D5053A045Q37701982-57A4E68E-1256-4449-8EF7-54989768BD12Q38650161-9294097B-4E92-4034-83D9-15D918FB601EQ38805367-2C252A58-0A8F-4284-9287-3CF9721A3D97Q38883878-ADFA1755-7139-42E0-B31F-C505879ACB5FQ38885740-017E8BB5-8ABF-4AC3-9565-5557B1F44EA1Q38939217-C912E4A3-BCE1-4A81-9D6B-2A0099855A78Q39145749-FCF37928-107D-4198-BD16-1B260834E438Q39301735-777DEDF8-A106-4DD0-8FBD-B906916360D0Q40205414-670D233B-16C4-4E0D-B05A-AB1FBE4F8236Q40671746-6F511825-51A4-47B2-A327-82F2130BD801Q41286620-7EE9FDFE-B1C9-43B3-8FB8-943B8CB49475Q41291393-8C933CCE-2556-4F0F-B935-FE816F8DFC6EQ41874352-B95D99A4-4E77-4168-BCCF-7654544E6D84Q42257121-5374FA15-F0C7-4242-9391-E2B6FFDF2065Q46143080-C75EDB7D-C6CE-4EA2-B6B8-2947AFD2F6E1Q46192328-F58E373D-E435-489B-84FD-7BCFDD0969F8Q47380947-9FF155F9-2DD8-4445-B747-F1CF03FAB300Q47688592-AFA63DCB-EAA8-4322-8278-1F182968A27DQ48113250-00DA70D1-2A5B-48BF-BDB1-D5DF32421DB6Q48417371-DD1F08A2-6743-4632-8A14-3361CB35027AQ48423771-5046F16A-2140-4B83-A6D5-98678D1F0BE5Q51743706-FD79D3CE-041E-4CE9-923B-5252854EF449Q52372478-65431522-0B70-4D75-9E7B-12660A8C71C1Q52668813-6ED0E900-273F-49BC-B703-859FBBB80364Q55453560-DC5AAE0C-1B21-4199-A168-CDB021B81196Q58462188-F9C7984A-BD26-4B50-8D05-54712B090CF1
P2860
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
@en
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
@nl
type
label
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
@en
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
@nl
prefLabel
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
@en
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia.
@en
P2093
P2860
P2888
P304
P356
10.1038/MP.2014.63
P407
P577
2014-07-22T00:00:00Z
P5875
P6179
1004708179